Last reviewed · How we verify
thalidomide and megestrol acetate
At a glance
| Generic name | thalidomide and megestrol acetate |
|---|---|
| Also known as | Chemotherapy drugs, optimal support treatment |
| Sponsor | Shenzhen Fifth People's Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- thalidomide and megestrol acetate CI brief — competitive landscape report
- thalidomide and megestrol acetate updates RSS · CI watch RSS
- Shenzhen Fifth People's Hospital portfolio CI